–
Given Imaging Ltd. (Nasdaq: GIVN; TASE: GIVN) announced that at a special shareholders’ meeting held today in Yoqneam, Israel, the Company approved the Merger with Ireland’s Covidien plc (NYSE: COV) by shareholders and by the Antitrust Authority.
The merger is now anticipated to close by the end of February 2014.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at office@jewishbusinessnews.com.
Thank you.
The merger includs the subsidiary of Covidien Group S.a.r.l., a Luxembourg company and an indirect, wholly-owned subsidiary of Covidien plc, as a result of which the Company will become a wholly-owned subsidiary of Covidien.
Covidien acquired all of Given Imaging’s shares at $30 per share, giving a valuation of $970 million, fully diluted (about $860 million excluding Given Imaging’s cash). Given Imaging has developed the PillCam endoscopic camera for the gastrointestinal tract.
The company began at Rafael Advanced Defense Systems Ltd., which converts military technology to civilian use through subsidiary Rafael Development Corporation.
Given Imaging’s technology is one of these developments. Given Imaging seen as an example of an Israeli successful medical devices company. The company went public on Nasdaq in 2001 and dual listed on the Tel Aviv Stock Exchange (TASE) in 2004.
